Health & Fitness
Health and Fitness
Health and Fitness
Thu, June 3, 2010 Somaxon Pharmaceuticals to Present at the Jefferies 2010 Global Life Sciences Conference
SAN DIEGO--([ BUSINESS WIRE ])--Somaxon Pharmaceuticals, Inc. (NASDAQ: SOMX) today announced that Richard W. Pascoe, Somaxona™s president and chief executive officer, will present at the Jefferies 2010 Global Life Sciences Conference at The Grand Hyatt Hotel in New York City on Thursday, June 10th at 11:30 a.m. Eastern Time.
A live webcast of the presentation will be available in the Investor Relations section of the companya™s Web site under Event Scheduler at [ www.somaxon.com ]. The webcast will be archived and accessible for at least 14 days.
About Somaxon Pharmaceuticals, Inc.
Headquartered in San Diego, CA, Somaxon Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the in-licensing, development and commercialization of proprietary branded pharmaceutical products and of late-stage product candidates for the treatment of diseases and disorders in the central nervous system therapeutic area. Somaxona™s product Silenor® (doxepin) has been approved by the FDA for the treatment of insomnia characterized by difficulty with sleep maintenance.
For more information, please visit the companya™s web site at [ www.somaxon.com ].
